Peterson Caryn
- SEC CIK
- 0001857256
No open-market purchases or sales filed in the past year.
Current role at each company
- GOSS Gossamer Bio, Inc.Chief Development Officeras of Aug 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Peterson Caryn as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 (view filing) | Mar 18 | 1 day | Peterson CarynEVP, Regulatory Affairs | SSale | −4.02K | $1.33 | −$5.34K | −7.5%49.8K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Peterson CarynEVP, Regulatory Affairs | SSale | −7.56K | $1.10 | −$8.32K | −12.3%53.9K after | |
| Oct 25, 2022 (view filing) | Oct 24 | 1 day | Peterson CarynEVP, Regulatory Affairs | SSale | −4.76K | $12.07 | −$57.4K | −7.2%61.4K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Peterson CarynEVP, Regulatory Affairs | SSale | −6.28K | $8.28 | −$52.0K | −8.7%66.2K after | |
| Oct 26, 2021 (view filing) | Oct 25 | 1 day | Peterson CarynEVP, Regulatory Affairs | SSale | −2.38K | $12.25 | −$29.1K | −3.2%72.5K after |